Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effekt av Kinesio -taping og laserterapi hos pasient med lymfødem på måling av omkrets (LYMPHEDEMA)

4. november 2026 oppdatert av: Mahmoud Awad Ramadan Elkholy, Beni-Suef University

Effekten av Kinesio -taping og laserterapi på lavt nivå hos pasient med post mastektomi relatert lymfødem ved måling av omkrets

find out the difference in the effect of kinesio taping and low level laser therapy on 90 patients with post mastectomy lymphedema as regards the following outcomes:

1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.

Studieoversikt

Detaljert beskrivelse

90 females with BCRL will be recruited in this study for 4 weeks , their age ranged from 40 to 55 years old with stege 1,2 lymphedema and randomly divided into 3 equal groups: 2) study group (A) include 30 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices 3) study group (B) include 30 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices 4) study group (C) include 30 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices regards the following outcomes:

1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.

Studietype

Intervensjonell

Registrering (Faktiske)

90

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt, 11865
        • Cairo University Hospital
      • GIZA, Cairo Governorate, Egypt, 11865
        • Cairo -Beni-Suif University Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

40 år til 55 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • persistence of lymphedema following mastectomy or breast conservative surgery for at least 3 months

    • minimum volume difference of 200 mL or an average difference in arm circumference of 2 cm or 10% between healthy and affected limbs.
    • Femal with unilateral lymphedema from 40 to 55 years old

Exclusion Criteria:

  • • Any disease lead to swelling

    • Medication especially diuretics
    • allergy
    • infection
    • pregnancy
    • heart band kidney disease
    • bilateral lymphedema
    • skin disease
    • chronic inflammatory disease

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: group A

study group (A) include 30 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices

  • the material used is 100%acrylic,latex free and heat activated with 10-15% stretch.
  • It is made of 100% cotton to allow quickening of the drying process.
  • Ability to stretch to 120-140% of its original length
  • Recoil back to the anchor that is applied without stretch
  • Heat-activated adhesive
  • Hypoallergenic dyes that make the tape safe for most users
  • Latex-free
  • Drying time after being wet is about 5-10 minutes
  • Can be worn for several days
Eksperimentell: Group B

study group (B) include 30 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices

The device has the following treatment parametes :

  • Maximum average power > 500 milli watts
  • Wave length combined (904-808) nm
  • Maximum repition rate (1-2000) Hz
  • Energy density : 4:6 J per cm per session
Eksperimentell: Group C

study group (C) include 30 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices

  • the material used is 100%acrylic,latex free and heat activated with 10-15% stretch.
  • It is made of 100% cotton to allow quickening of the drying process.
  • Ability to stretch to 120-140% of its original length
  • Recoil back to the anchor that is applied without stretch
  • Heat-activated adhesive
  • Hypoallergenic dyes that make the tape safe for most users
  • Latex-free
  • Drying time after being wet is about 5-10 minutes
  • Can be worn for several days

The device has the following treatment parametes :

  • Maximum average power > 500 milli watts
  • Wave length combined (904-808) nm
  • Maximum repition rate (1-2000) Hz
  • Energy density : 4:6 J per cm per session

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
girth measurment
Tidsramme: 4 weeks

Measurement of arm circumference is the most commonly used technique for identifying lymphedema and is reliable for both surgical and nonsurgical upper limbs It is measured using a tape with the patient in prone lying position, with elbows straight and arms relaxed at the sides. It was measured starting with 3 cm on the ulnar styloid process and proceeding with 45 cm proximal, and additionally at the metacarpal bones and mid-hand. The tape measure was put around the limb to prevent it from slacking and to ensure that there was no space in the tissue. The total circumference of the sound limb was ascertained similarly. The difference between the 2 measurements was identified using "circumference difference."

4 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
shoulder pain and disability index
Tidsramme: 4 weeks

was used to assess shoulder pain and disability. It incorporates 13 items assessing 2 domains: 5 items assess pain and 8 items evaluate disability.

4 weeks
quality of life questionnaire
Tidsramme: 4 weeks

was assessed by cancer-specific questionnaire (EORTC QLQ-C30). It is composed of 30 questions, including functional scores (physical, social, emotional, and cognitive aspects). The functional scores ranged between 0 and 100, and higher scores indicated better condition. This questionnaire also included symptoms score (pain, dyspnea, fatigue, insomnia, nausea, loss of appetite, and financial problems). The symptom scores ranged from 100 to 0, and lower scores indicated better condition

4 weeks
handgrip strength
Tidsramme: 4 week

evaluated using a dynamometer ,The grip strength was measured with the patient in a standing position with adducted shoulder, elbow flexed at 90°, and forearm in mid position. The patient was instructed to do 3 trials with 15 seconds rest in between each, and the highest reading was reported

4 week

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: MAHMOUD AWD ELKHOLY, Lecturer of physical therapy, beni suif university
  • Hovedetterforsker: MERIT MAGDY ZAKI, physiotherapist, beni suif university
  • Studiestol: SHERIN HASSAN MEHANI, Professor of Physical therapy, beni suif university

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. februar 2025

Primær fullføring (Faktiske)

1. september 2025

Studiet fullført (Faktiske)

1. september 2025

Datoer for studieregistrering

Først innsendt

29. januar 2025

Først innsendt som oppfylte QC-kriteriene

29. januar 2025

Først lagt ut (Faktiske)

5. februar 2025

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

6. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

4. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere